Ken Griffin’s AYTU BioPharma AYTU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-30,493
| Closed | -$36.6K | – | 5848 |
|
|
2025
Q1 | $36.6K | Buy |
30,493
+19,431
| +176% | +$23.3K | ﹤0.01% | 5452 |
|
|
2024
Q4 | $18.5K | Buy |
+11,062
| New | +$18.5K | ﹤0.01% | 5656 |
|
|
2024
Q3 | – | Sell |
-21,810
| Closed | -$63.5K | – | 5798 |
|
|
2024
Q2 | $63.5K | Buy |
21,810
+9,635
| +79% | +$28K | ﹤0.01% | 5108 |
|
|
2024
Q1 | $37K | Buy |
+12,175
| New | +$37K | ﹤0.01% | 5394 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6056 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5867 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5993 |
|
|
2022
Q1 | – | Sell |
-4,906
| Closed | -$132K | – | 6329 |
|
|
2021
Q4 | $132K | Buy |
4,906
+528
| +12% | +$14.2K | ﹤0.01% | 5746 |
|
|
2021
Q3 | $252K | Buy |
4,378
+3,159
| +259% | +$182K | ﹤0.01% | 5185 |
|
|
2021
Q2 | $122K | Sell |
1,219
-19
| -2% | -$1.9K | ﹤0.01% | 5870 |
|
|
2021
Q1 | $188K | Sell |
1,238
-2,946
| -70% | -$447K | ﹤0.01% | 5458 |
|
|
2020
Q4 | $500K | Buy |
4,184
+4,128
| +7,371% | +$493K | ﹤0.01% | 3857 |
|
|
2020
Q3 | $13K | Buy |
+56
| New | +$13K | ﹤0.01% | 4566 |
|
|
2020
Q2 | – | Sell |
-208
| Closed | -$62K | – | 4623 |
|
|
2020
Q1 | $62K | Buy |
+208
| New | +$62K | ﹤0.01% | 4500 |
|
|
2019
Q4 | – | Sell |
-64
| Closed | -$15K | – | 4616 |
|
|
2019
Q3 | $15K | Buy |
+64
| New | +$15K | ﹤0.01% | 4551 |
|
|
2019
Q1 | – | Sell |
-141
| Closed | -$22K | – | 4517 |
|
|
2018
Q4 | $22K | Buy |
+141
| New | +$22K | ﹤0.01% | 4235 |
|
|
2018
Q3 | – | Sell |
-77
| Closed | -$81K | – | 4271 |
|
|
2018
Q2 | $81K | Buy |
77
+55
| +250% | +$57.9K | ﹤0.01% | 3859 |
|
|
2018
Q1 | $56K | Buy |
+22
| New | +$56K | ﹤0.01% | 3731 |
|